[HTML][HTML] Imidazoles as potential anticancer agents: An update on recent studies

P Sharma, C LaRosa, J Antwi, R Govindarajan… - Molecules, 2021‏ - mdpi.com
Nitrogen-containing heterocyclic rings are common structural components of marketed
drugs. Among these heterocycles, imidazole/fused imidazole rings are present in a wide …

Recent advances in the transition-metal-free synthesis of quinoxalines

B Borah, LR Chowhan - RSC advances, 2021‏ - pubs.rsc.org
Quinoxalines, also known as benzo [a] pyrazines, constitute an important class of nitrogen-
containing heterocyclic compounds as a result of their widespread prevalence in natural …

Synthesis, non-covalent interactions and chemical reactivity of 1-pentyl-3-phenylquinoxalin-2 (1H)-one—Structural and computational studies

N Abad, L Guelmami, A Haouas, M Hajji… - Journal of Molecular …, 2023‏ - Elsevier
This contribution presents the synthesis of a new quinoxaline derivative, 1-pentyl-3-
phenylquinoxalin-2 (1H)-one with formula C 19 H 20 N 2 O, through an alkylation reaction …

Recent advances on quinoxalines as target‐oriented chemotherapeutic anticancer agents through apoptosis

MS Nafie, SH Kahwash, MM Youssef… - Archiv der …, 2024‏ - Wiley Online Library
The current review outlines all possible recent synthetic platforms to quinoxaline derivatives
and the potent stimulated apoptosis mechanisms targeted by anticancer therapies. The …

Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile …

G Teli, R Pal, L Maji, S Sengupta… - Chemistry & …, 2023‏ - Wiley Online Library
The physiological Src proto‐oncogene is a protein tyrosine kinase receptor that served as
the essential signaling pathway in different types of cancer. Src kinase receptor is divided …

Novel penta-1, 4-diene-3-one derivatives containing quinazoline and oxime ether fragments: Design, synthesis and bioactivity

S Su, M Chen, Q Li, Y Wang, S Chen, N Sun… - Bioorganic & Medicinal …, 2021‏ - Elsevier
A series of novel penta-1, 4-diene-3-one derivatives containing quinazoline and oxime ether
moieties were designed and synthesized. Their anticancer activities were evaluated by MTT …

Recent updates on the anticancer activity of quinoxaline hybrids (Jan. 2017-Jan. 2022)

LS Feng, C Gao, FW Liu, XP Wang… - Current topics in …, 2022‏ - benthamdirect.com
Cancer being one of the leading causes of death among non-communicable diseases, has
already posed a heavy burden on the world health system. Chemotherapy is one of the most …

Recent advances in the development of nitrogencontaining heterocyclic compounds as anticancer agents: a review

W Ettahiri, M Saber, Z Ouzrour, S Lahmidi… - Moroccan Journal of …, 2023‏ - revues.imist.ma
N-heterocyclic compounds are a natural and rich source of pharmacologically active
molecules displaying anti-cancer properties through various antiproliferative mechanisms …

Imidazoquinoxaline as a privileged fused pharmacophore in anticancer drug development: a review of synthetic strategies and medicinal aspects

KK Goel, SK Rajput, A Kumar, NK Nandi… - …, 2022‏ - Wiley Online Library
Cancer, the uncontrolled growth of cells, is not a single but a multifaceted disorder with
malignant behavior, metastasis, and invasion, medically known as malignant neoplasm. The …

Discovery of 1, 4-pentadien-3-one derivatives containing quinoxaline scaffolds as potential apoptosis inducers

X Tang, J He, Q Li, X Tang, M Chen, G Hao… - Future medicinal …, 2020‏ - Taylor & Francis
Aim: To synthesize novel antiproliferative agents. Results & methodology: A variety of 1, 4-
pentadien-3-one derivatives bearing quinoxaline scaffolds was designed and synthesized …